Towards Healthcare

Breath Analyzers Companies and Market Trends Analysis

Date : 16 October 2025

Breath Analyzers Market Companies and Market Growth

Breath Analyzers Market Companies

  • Dräger / Drägerwerk
  • Lifeloc Technologies
  • Lion Laboratories / LION
  • BACtrack
  • Intoximeters, Inc.
  • Intoxalock
  • Smart Start
  • LifeSafer
  • AlcoPro / AlcoPro, Inc.
  • Bedfont Scientific
  • Owlstone Medical
  • Sensit Technologies / Sensit
  • Figaro Engineering / Figaro USA
  • City Technology / Honeywell
  • Sensirion / Bosch Sensortec / Bosch
  • Picarro / PTR-MS / Ionicon
  • Alcohawk / AlcoHAWK
  • Regional OEMs / China-based device makers
  • Ignition interlock program managers & monitoring platforms
  • Contract manufacturers & sensor module OEMs

Market Growth

The global breath analyzers market size is calculated at US$ 1.022 billion in 2024, grew to US$ 1.2 billion in 2025, and is projected to reach around US$ 5.12 billion by 2034. The market is expanding at a CAGR of 17.44% between 2025 and 2034.

Increasing Personal Use: Due to growing awareness, there is a rise in the use of breath analyzers. This, in turn, is increasing their adoption by the consumers to avoid the risk of alcohol related accidents. Moreover, their availability on online platforms is increasing their adoption rates.

Growing Research and Development: There is an increase in the research and development of breath analyzers for enhancing applications. This, in turn, is leading to new collaborations among the industries as well as institutes. They are focusing on improving their accuracy and specificity, as well as innovations for the early detection of different diseases.

For instance,

  • In August 2025, a collaboration between Cannabix Technologies and Omega Laboratories Inc. was announced. To improve the detection of recent cannabis use. The breath testing technology of Cannabix will be combined with the drug testing services of Omega in this collaboration.

Breath Analyzers Market Value Chain Analysis

R&D

The R&D of breath analyzers focuses on enhancing their accuracy, portability, sensitivity, and versatility to increase their applications, along with growing advancements in sensor technologies.

Key Players: Intoximeters, Drägerwerk, Inc., BACtrack, Lifeloc Technologies

Clinical Trials and Regulatory Approvals

The clinical trials and regulatory approval of the breath analyzers focus on the detection of risk levels for medical diagnostics.

Key Players: Lifeloc Technologies, Drägerwerk, Inc., Lion Laboratories, Intoximeters

Packaging and Serialization

The packaging and serialization of breath analyzers include packaging that protects their integrity, mouthpiece sterile materials, and a unique device identification (UDI) system for their regulatory traceability.

Key Players: DuPont de Nemours Inc., Berry Global, Amcor Plc, Oliver Healthcare Packaging, CCL Healthcare

Patient Support and Services

User instructions, test preparation and interpretation information, and technical support are provided in the patient support and services of the breath analyzer.

Key Players: BACtrack, Lifeloc Technologies, FoodMarble Digestive Health Ltd., Drägerwerk

What is the Latest Announcement by the Industry Leader in the Breath Analyzers Market?

In April 2025, after announcing the non-exclusive distribution agreement between Cannabix Technologies Inc. and Alco Prevention Canada, the CEO of Cannabix Technologies, Rav Mlait, stated that truly innovative new technologies are being supplied to the marketplace for breath testing by Cannabix. New opportunities for the development of disruptive and innovative technologies are being provided by the growing breath testing for marijuana and alcohol segment, which will be the main focus of Cannabix, aiming to achieve new milestones in 2025.

What are the Recent Developments in the Breath Analyzers Market?

  • In June 2025, to monitor diabetes, a breath analyzer that can measure acetone levels in exhaled breath was developed by Chinese scientists. The Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, conducted this study.
  • In April 2025, 80-92% accuracy was achieved by electronic nose breath analysis in the detection of lung cancer. The accuracy remained consistent irrespective of the tumor characteristics, clinical factors, disease stage, and diagnostic centers.

Become a valued research partner with us, please feel free to contact us at sales@towardshealthcare.com